Central Pacific Bank - Trust Division’s AstraZeneca AZN Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$982K	Buy	+5,179	New	+$974K	0.1%	197
2026 Q1	–	Sell	-5,180	Closed	-$952K	–	863
2025 Q4	$952K	Buy	+5,180	New	+$908K	0.12%	183
2025 Q1	–	Sell	-21	Closed	-$2.75K	–	850
2024 Q4	$2.75K	Hold	21	–	–	﹤0.01%	787
2024 Q3	$3.27K	Hold	21	–	–	﹤0.01%	766
2024 Q2	$3.28K	Hold	21	–	–	﹤0.01%	844
2024 Q1	$2.83K	Buy	+21	New	+$2.78K	﹤0.01%	846

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Central Pacific Bank - Trust Division's AZN Position: Q2 2026 in Review

Central Pacific Bank - Trust Division opened a new position in AstraZeneca (AZN) in Q2 2026: 5,179 shares worth $982K. The stake represents 0.1% of the portfolio and ranks #197 among its holdings. This is a return to the name: Central Pacific Bank - Trust Division previously reported a position in AZN as recently as Q4 2025.

Central Pacific Bank - Trust Division first reported a position in AZN in Q1 2024 and has held it in 6 quarters since. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Central Pacific Bank - Trust Division held 5,179 shares of AstraZeneca worth $982K as of Q2 2026.
AstraZeneca was a new Central Pacific Bank - Trust Division position in Q2 2026.
AstraZeneca made up 0.1% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #197 holding.
Central Pacific Bank - Trust Division first reported a position in AstraZeneca in Q1 2024 and has held it in 6 quarters since.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.